Publications
202
Citations
2,351
Est. group size
~34
Recurring co-author estimate
Active years
30
Publishing since 1997
This publication record spans a very wide range of topics in cancer biology, genetics, kidney disease, cardiovascular biology, and other areas, suggesting involvement as a collaborator or statistical/genomics contributor across many different research projects rather than a single focused lab. Common threads include cancer treatment and resistance mechanisms, gene expression regulation (such as RNA splicing), and genetic analysis methods applied to disease. Prospective students should note that the bibliographic data alone does not clarify a single unifying research question, and the role in these collaborative works is not specified.
Publication output grew substantially from 2017 to a peak in 2023, followed by a decline in 2024-2025, suggesting a period of increased activity followed by a recent slowdown.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma
Molecular Therapy Oncology · 2025
- RNA Alternative Splicing and Polyadenylation and Regulation of the Glomerular Filtration Barrier
Journal of the American Society of Nephrology · 2025
- Holding time or fixative formulation has no obvious effect on histology of <i>Porites evermanni</i> and <i>Montipora capitata</i>
Veterinary Pathology · 2025
- Radiation-Induced HMGB2 Cytoplasmic Translocation Associates with Enhanced Immune Response Pathways in Glioma
International Journal of Radiation Oncology*Biology*Physics · 2025
- Loss of Regulator of G Protein Signaling 11 Promotes Protumorigenic Features in Pancreatic Cancer
Molecular Cancer Research · 2025
- RNA Alternative Splicing and Polyadenylation and Regulation of the Glomerular Filtration Barrier
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Abstract 4138019: eQTL Analysis of the PAH Biomarker CCN2 Identifies a Novel SNP that Associates with Survival
Circulation · 2024
- Neointima abating and endothelium preserving — An adventitia-localized nanoformulation to inhibit the epigenetic writer DOT1L
Biomaterials · 2023
- Supplementary Data from Deregulation of AKT–mTOR Signaling Contributes to Chemoradiation Resistance in Lung Squamous Cell Carcinoma
2023
- Supplementary Data from Deregulation of AKT–mTOR Signaling Contributes to Chemoradiation Resistance in Lung Squamous Cell Carcinoma
2023
- PD-0235 Variation in incidental dose to the axilla in patients treated with whole breast radiotherapy alone
Radiotherapy and Oncology · 2023
- Abstract 631: Neointima Abating Yet Endothelium Preserving-An Adventitia-localized Nanoformulation To Inhibit The Epigenetic Writer Dot1L
Arteriosclerosis Thrombosis and Vascular Biology · 2023
- Data from Deregulation of AKT–mTOR Signaling Contributes to Chemoradiation Resistance in Lung Squamous Cell Carcinoma
2023
- Data from Deregulation of AKT–mTOR Signaling Contributes to Chemoradiation Resistance in Lung Squamous Cell Carcinoma
2023
- Nephrin, Podocin, and Neph1 Encoding mRNAs Are Dysregulated by Alternative Polyadenylation During Podocyte Injury
Journal of the American Society of Nephrology · 2023
- bioRxiv (Cold Spring Harbor Laboratory)×13
- Blood×8
- Neuro-Oncology×6
- International Journal of Radiation Oncology*Biology*Physics×6
- Circulation×5
- Mikhail Tarasov
Medicine · The Ohio State University
- Matthew F. Kalady
Medicine · The Ohio State University
- Yuan Zhou
Medicine · Indiana University
- Wei Chen
Medicine · The Ohio State University
- Alan Harzman
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile